Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice.

Schumacher U, Nehmann N, Adam E, Mukthar D, Slotki IN, Horny HP, Flens MJ, Schlegelberger B, Steinemann D.

Acta Histochem. 2012 Oct;114(6):594-602. doi: 10.1016/j.acthis.2011.11.004. Epub 2011 Dec 7.

PMID:
22154301
[PubMed - indexed for MEDLINE]
2.

In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.

Lorke DE, Krüger M, Buchert R, Bohuslavizki KH, Clausen M, Schumacher U.

J Nucl Med. 2001 Apr;42(4):646-54.

PMID:
11337555
[PubMed - indexed for MEDLINE]
Free Article
3.

Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.

Hill AB, Beck WT, Trent JM.

Cancer Res. 1988 Jan 15;48(2):393-8.

PMID:
2891436
[PubMed - indexed for MEDLINE]
Free Article
4.

Glycosylation patterns of the human colon cancer cell line HT-29 detected by Helix pomatia agglutinin and other lectins in culture, in primary tumours and in metastases in SCID mice.

Schumacher U, Adam E, Flavell DJ, Boehm D, Brooks SA, Leathem AJ.

Clin Exp Metastasis. 1994 Nov;12(6):398-404.

PMID:
7923992
[PubMed - indexed for MEDLINE]
5.

The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro.

Valentiner U, Pfüller U, Baum C, Schumacher U.

Toxicology. 2002 Feb 28;171(2-3):187-99.

PMID:
11836024
[PubMed - indexed for MEDLINE]
6.

The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation.

Sharma R, Adam E, Schumacher U.

Br J Cancer. 1997;76(8):1011-6.

PMID:
9376259
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.

Stein U, Walther W, Lemm M, Naundorf H, Fichtner I.

Int J Cancer. 1997 Sep 4;72(5):885-91.

PMID:
9311609
[PubMed - indexed for MEDLINE]
8.
9.

In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.

Márián T, Szabó G, Goda K, Nagy H, Szincsák N, Juhász I, Galuska L, Balkay L, Mikecz P, Trón L, Krasznai Z.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1147-54. Epub 2003 Jun 27.

PMID:
12830325
[PubMed - indexed for MEDLINE]
10.

Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.

Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C, Fidler IJ.

J Natl Cancer Inst. 1994 Jun 15;86(12):913-20.

PMID:
7910854
[PubMed - indexed for MEDLINE]
11.

[Effects of antisense 6 gene on colon cancer cells].

Zhang ZY, Xu KS, Yang GY, Wang JS, Gao Y, Liu YF, Shuai J, Wang JY, Li SY, Shou NH, Niu J.

Zhonghua Yi Xue Za Zhi. 2007 Oct 9;87(37):2645-8. Chinese.

PMID:
18162155
[PubMed - indexed for MEDLINE]
12.

Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.

Etievant C, Barret JM, Kruczynski A, Perrin D, Hill BT.

Invest New Drugs. 1998;16(1):3-17.

PMID:
9740539
[PubMed - indexed for MEDLINE]
13.

Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy.

Niethammer AG, Wodrich H, Loeffler M, Lode HN, Emmerich K, Abdollahi A, Krempien R, Debus J, Huber PE, Reisfeld RA.

FASEB J. 2005 Jan;19(1):158-9. Epub 2004 Oct 21.

PMID:
15498893
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.

Yano S, Hanibuchi M, Nishioka Y, Nokihara H, Nishimura N, Tsuruo T, Sone S.

Int J Cancer. 1999 Jul 2;82(1):105-11.

PMID:
10360828
[PubMed - indexed for MEDLINE]
16.

E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.

Köhler S, Ullrich S, Richter U, Schumacher U.

Br J Cancer. 2010 Feb 2;102(3):602-9. doi: 10.1038/sj.bjc.6605492. Epub 2009 Dec 15.

PMID:
20010946
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13.

PMID:
20464481
[PubMed - indexed for MEDLINE]
18.

Cell differentiation and chemotherapy influence p53 and Mdm2 immunoreactivity in human HT29 colon cancer cells grown in scid mice.

Schumacher U, Adam E, Feldhaus S, Katoh M, Lane DP.

Cancer Lett. 2001 May 26;166(2):215-21.

PMID:
11311495
[PubMed - indexed for MEDLINE]
19.

Molecular mechanisms of multidrug resistance in cancer chemotherapy.

Nooter K, Stoter G.

Pathol Res Pract. 1996 Jul;192(7):768-80. Review.

PMID:
8880878
[PubMed - indexed for MEDLINE]
20.

Multidrug resistance and malignancy in human osteosarcoma.

Scotlandi K, Serra M, Nicoletti G, Vaccari M, Manara MC, Nini G, Landuzzi L, Colacci A, Bacci G, Bertoni F, Picci P, Campanacci M, Baldini N.

Cancer Res. 1996 May 15;56(10):2434-9.

PMID:
8625324
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk